Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CERO | CERO THERAPEUTICS HOLDINGS INC | $85.58k | $0.07 | $45.00 | 63,280.28% | Strong Buy | 2 | N/A | N/A | N/A | -503.12% | |||
| KALA | KALA BIO INC | $5.03M | $0.78 | $32.67 | 4,088.08% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $20.22M | $0.39 | $13.00 | 3,207.89% | Strong Buy | 2 | N/A | N/A | -35,899.88% | -513.21% | |||
| ACXP | ACURX PHARMACEUTICALS INC | $7.96M | $5.02 | $95.50 | 1,802.39% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| IMA | IMAGENEBIO INC | $35.03M | $8.71 | $153.00 | 1,656.60% | Buy | 2 | N/A | N/A | -21.45% | -19.70% | |||
| ATYR | ATYR PHARMA INC | $77.08M | $0.87 | $13.63 | 1,473.33% | Buy | 4 | N/A | N/A | -38.51% | -29.72% | |||
| PSTV | PLUS THERAPEUTICS INC | $74.21M | $0.54 | $8.00 | 1,381.48% | Strong Buy | 4 | 55.70% | N/A | -83.21% | -22.52% | |||
| MRSN | MERSANA THERAPEUTICS INC | $47.81M | $9.58 | $140.00 | 1,361.38% | Strong Buy | 2 | -29.73% | N/A | N/A | -29.19% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $180.42M | $0.60 | $8.33 | 1,293.48% | Strong Buy | 3 | 9.48% | N/A | 240.73% | 48.37% | |||
| GRI | GRI BIO INC | $4.28M | $1.70 | $22.50 | 1,223.53% | Buy | 2 | N/A | N/A | -26.77% | -15.67% | |||
| FGEN | FIBROGEN INC | $44.97M | $11.12 | $146.50 | 1,217.45% | Buy | 2 | N/A | N/A | N/A | -19.48% | |||
| NRXP | NRX PHARMACEUTICALS INC | $61.09M | $3.10 | $40.33 | 1,201.06% | Strong Buy | 3 | N/A | N/A | -282.17% | 2,077.22% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $29.84M | $2.05 | $26.67 | 1,200.83% | Buy | 3 | 307.92% | N/A | N/A | -57.00% | |||
| TVRD | TVARDI THERAPEUTICS INC | $43.61M | $4.65 | $55.50 | 1,093.55% | Strong Buy | 6 | -87.30% | N/A | -101.00% | -76.02% | |||
| FEMY | FEMASYS INC | $17.35M | $0.64 | $7.00 | 998.90% | Strong Buy | 2 | 155.46% | N/A | -125.24% | -18.83% | |||
| CING | CINGULATE INC | $20.51M | $3.79 | $39.50 | 942.22% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| SKYE | SKYE BIOSCIENCE INC | $48.03M | $1.55 | $15.00 | 867.74% | Buy | 3 | N/A | N/A | -163.55% | -136.95% | |||
| MDCX | MEDICUS PHARMA LTD | $43.47M | $2.44 | $23.50 | 863.11% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $25.05M | $1.05 | $10.00 | 852.38% | Strong Buy | 2 | N/A | N/A | -120.06% | -101.23% | |||
| IMUX | IMMUNIC INC | $74.64M | $0.78 | $7.00 | 798.59% | Strong Buy | 4 | N/A | N/A | -1,067.64% | 275.15% | |||
| JSPR | JASPER THERAPEUTICS INC | $37.06M | $2.28 | $20.14 | 783.46% | Buy | 7 | N/A | N/A | -217.81% | -110.16% | |||
| MBRX | MOLECULIN BIOTECH INC | $14.08M | $0.47 | $4.00 | 760.22% | Buy | 2 | N/A | N/A | N/A | -603.73% | |||
| MYO | MYOMO INC | $35.00M | $0.93 | $7.83 | 745.90% | Buy | 3 | 13.66% | N/A | 41.18% | 18.76% | |||
| LSTA | LISATA THERAPEUTICS INC | $23.99M | $2.79 | $23.50 | 742.29% | Strong Buy | 2 | 63.92% | N/A | -33.90% | -29.66% | |||
| PMN | PROMIS NEUROSCIENCES INC | $21.76M | $0.42 | $3.50 | 733.33% | Strong Buy | 2 | N/A | N/A | N/A | -398.95% | |||
| VNRX | VOLITIONRX LTD | $46.27M | $0.43 | $3.50 | 713.95% | Strong Buy | 3 | 262.15% | N/A | -322.53% | 1,178.82% | |||
| ACET | ADICET BIO INC | $62.03M | $0.75 | $6.00 | 700.00% | Strong Buy | 2 | N/A | N/A | -24.95% | -21.06% | |||
| BMEA | BIOMEA FUSION INC | $80.93M | $1.36 | $10.50 | 672.06% | Strong Buy | 6 | N/A | N/A | -277.27% | -104.26% | |||
| PASG | PASSAGE BIO INC | $24.41M | $7.68 | $59.25 | 671.48% | Strong Buy | 4 | N/A | N/A | -2.97% | -1.43% | |||
| MTVA | METAVIA INC | $24.03M | $0.99 | $7.50 | 655.29% | Strong Buy | 2 | N/A | N/A | -1,174.59% | -612.40% | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $11.57M | $9.17 | $65.00 | 608.83% | Buy | 2 | N/A | N/A | -67.83% | -58.29% | |||
| TIL | INSTIL BIO INC | $119.08M | $17.64 | $125.00 | 608.62% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| CTSO | CYTOSORBENTS CORP | $49.78M | $0.80 | $5.50 | 591.82% | Buy | 2 | 21.29% | N/A | N/A | N/A | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $11.74M | $2.05 | $14.00 | 582.93% | Buy | 2 | N/A | N/A | -23.72% | -21.19% | |||
| RNXT | RENOVORX INC | $40.68M | $1.11 | $7.50 | 575.68% | Buy | 2 | 283.58% | N/A | 94.84% | 73.97% | |||
| FOLD | AMICUS THERAPEUTICS INC | $2.78B | $9.03 | $61.00 | 575.53% | Strong Buy | 2 | 17.19% | N/A | 236.99% | 59.39% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $114.96M | $0.89 | $5.88 | 560.11% | Buy | 2 | N/A | N/A | -74.22% | -66.37% | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $275.13M | $1.24 | $8.00 | 545.16% | Strong Buy | 7 | N/A | N/A | -46.85% | -34.31% | |||
| EKSO | EKSO BIONICS HOLDINGS INC | $14.14M | $5.39 | $34.75 | 544.71% | Strong Buy | 2 | 27.79% | N/A | -4.15% | -1.85% | |||
| ANVS | ANNOVIS BIO INC | $40.92M | $2.10 | $13.50 | 542.86% | Strong Buy | 2 | N/A | N/A | -166.98% | -142.67% | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $11.06M | $5.76 | $35.67 | 519.22% | Buy | 3 | 37.00% | N/A | -109.83% | -56.51% | |||
| NEUP | NEUPHORIA THERAPEUTICS INC | $10.73M | $4.55 | $28.00 | 515.38% | Strong Buy | 2 | -100.00% | N/A | -59.15% | -39.32% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.